Announcements Trials

Browse Landscape

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Hyperthermia 20 Sarcoma 7 Uterine Cervical Neoplasms 4 Rectal Neoplasms 4 Prostatic Neoplasms 4 Head and Neck Neoplasms 4 Melanoma 3 Colonic Neoplasms 3 Carcinoma, Hepatocellular 3 Breast Neoplasms 3 Urinary Bladder Neoplasms 2 Ovarian Neoplasms 2 Neoplasms 2 Neoplasm Metastasis 2 Squamous Cell Carcinoma of Head and Neck 1 Solid Tumors 1 Sarcoma, Synovial 1 Sarcoma, Clear Cell 1 Sarcoma, Alveolar Soft Part 1 Salivary Gland Adenoma, Pleomorphic 1 Recurrence 1 Prehypertension 1 Prediabetic State 1 Polycystic Ovary Syndrome 1 Peritoneal Neoplasms 1 Pelvic Pain 1 Oropharyngeal Neoplasms 1 Obesity 1 Neurofibrosarcoma 1 Neoplasms, Radiation-Induced 1

Interventions

Gemcitabine 7 Doxorubicin 4 Cyclophosphamide 4 pembrolizumab 3 Magnetic Resonance Spectroscopy 3 Docetaxel 3 Cisplatin 3 regorafenib 2 Vincristine 2 Tranexamic Acid 2 Sunitinib 2 Standard of Care 2 Radiotherapy, Intensity-Modulated 2 Radiosurgery 2 Radiation 2 Proton Therapy 2 Nivolumab 2 Methotrexate 2 Methods 2 Interviews as Topic 2 Indocyanine Green 2 Everolimus 2 Curettage 2 Ascorbic Acid 2 3-(5-fluorobenzofuran-3-yl)-4-(5-methyl-5H-(1,3)dioxolo(4,5-f)indol-7-yl)-pyrrole-2,5-dione 2 tocilizumab 1 samarium Sm-153 lexidronam 1 poly ICLC 1 pegylated granulocyte colony-stimulating factor 1 pegfilgrastim 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

OTHER × Bone Neoplasms × Diathermy × Clear all

NCT02153593 2016-09-20

TRANEXTUM

Fundació Institut de Recerca de l'Hospital de la Santa Creu i Sant Pau

Phase 3 Terminated

Bone Neoplasms, Hemorrhage

Data powered by HemOnc (CC BY 4.0) Colophon ⚡